Health

President Trump’s May 12 Executive Order around Most-Favored-Nation drug pricing argues that countries outside the US need to raise their prices on pharmaceuticals saying that many other countries are “freeloading” and paying less than their share for pharmaceuticals. In response, pharmaceutical companies have increased prices in the UK and even threatened to “walk away” from…

Last month, the American Heart Association (AHA) and American College of Cardiology (ACA) put out a statement on how new cardiovascular medical technologies should be evaluated from a cost and value standpoint (Kazi et al. 2025). This is an update from their 2014 cost/value methodology (Anderson et al. 2014). What does the AHA/ACC statement say?…

Impact of the government shutdown on health services. Why do patients with sickle cell disease disproportionately leave hospitals against medical advice? New estimates of upcoding. TrumpRx. “FDA will not be able to accept applications for new drugs, generics, biologics, biosimilars or medical devices that require payment of a user fee while the shutdown is in…

How does patient quality of life impact caregiving burden? Often this is determined using caregiver surveys. However, a paper by Jiao et al. (2025) aims to use a data based approach to help estimate caregiver burden. They The authors use data from the 2010-2018 Health and Retirement Survey (HRS). HRS data was selected because there…

EndPoints notes that the Most Favored Nation Executive Order has led some large pharmaceutical firms to make two changes: (i) start charging Europeans the same price as the US, and (ii) start selling more products direct to consumer (a.k.a. ‘pharm to table‘) AbbVie, Novartis and Boehringer Ingelheim each joined their peers in making price-related concessions…